Progressive retinal atrophy (PRA) in cats is a group of inherited diseases in which the light-sensing cells of the retina gradually deteriorate, eventually leading to blindness. Unlike sudden vision loss from injury or infection, PRA unfolds over months to years, and because cats adapt so well to dimming sight, owners sometimes don’t notice anything is wrong until the disease is advanced. Several distinct genetic mutations cause PRA in different breeds, and researchers have identified forms affecting Abyssinians, Somalis, Siamese, Persians, Bengals, and over a dozen other breeds.
Which Breeds Are at Risk
The most thoroughly studied form of feline PRA is called rdAc, caused by a mutation in the CEP290 gene. It was first characterized in Abyssinian and Somali cats, but a large genetic survey across 41 breeds found the rdAc mutation in a surprising number of them. The faulty allele turned up in 37% of breeds tested, and Siamese populations in both North America and Europe carried it at a particularly high frequency of roughly 33%.1PubMed Central. Widespread retinal degenerative disease mutation (rdAc) discovered among a large number of popular cat breeds That means the problem extends well beyond the handful of breeds traditionally associated with PRA. Ocicat, American Shorthair, Cornish Rex, and several other popular breeds have also been found to carry the mutation.
Persian cats have their own genetically distinct form of PRA. Breeders long believed that only chocolate-coated or Himalayan (pointed) Persians were at risk, but a study that genetically typed 60 related Persians for coat-color mutations and PRA found no association between coat color and the disease.2PubMed Central. Lack of genetic association among coat colors, progressive retinal atrophy and polycystic kidney disease in Persian cats The practical takeaway for breeders is that PRA in Persians is likely more common than commonly claimed, because it is not confined to specific color lines. Genome-wide analysis has since mapped the Persian PRA locus to a region on cat chromosome E1, which corresponds to part of human chromosome 17.3PubMed Central. Genome-wide association and linkage analyses localize a progressive retinal atrophy locus in Persian cats
Bengal cats have yet another form. Pedigree analysis and breeding studies confirmed it follows autosomal recessive inheritance, and genetic testing showed it is not caused by the CEP290 or CRX mutations found in Abyssinians and Siamese.4PubMed Central. Characterization of an Early-Onset, Autosomal Recessive, Progressive Retinal Degeneration in Bengal Cats So “PRA” in cats is really an umbrella term for several genetically independent diseases that happen to share the same outcome: progressive destruction of the retina.
Recessive, Dominant, and Why the Distinction Matters
Most forms of feline PRA are autosomal recessive, meaning a cat must inherit two copies of the faulty gene (one from each parent) to develop the disease. Cats carrying just one copy look perfectly healthy and see perfectly well, but they can pass the mutation to their kittens. That is exactly why rdAc has spread so widely: carrier cats breed successfully for years, and without genetic testing, there is no way to tell them apart from cats that carry no copies at all.
One notable exception is the CRX mutation, found primarily in cats derived from Siamese lines. This variant is dominant, meaning a single copy is enough to cause disease. Cats with this mutation serve as a model for a severe human condition called Leber congenital amaurosis, and vision loss tends to begin much earlier in life than with the recessive forms.5PubMed. Metabolic changes and retinal remodeling in Heterozygous CRX mutant cats (CRX(RDY/+)) Because only one copy is needed, the disease is harder to hide in a breeding population and, in theory, easier to eliminate through screening. In practice, though, cats carrying the CRX mutation can still be bred before their vision loss becomes obvious, especially if breeders aren’t testing.
For owners, the recessive-versus-dominant distinction affects what genetic testing means. A cat that tests positive as a carrier for rdAc will never go blind from the disease itself, but breeding two carriers together gives each kitten a one-in-four chance of being affected. A cat that tests positive for the dominant CRX mutation, on the other hand, will develop retinal degeneration regardless of what its mate carries.
How the Disease Unfolds
PRA does not strike all at once. In the most common rdAc form, the first cells to degenerate are the rods, which handle dim-light and peripheral vision. Ultrastructural studies of Abyssinian cats at around two years of age found disorganized and abnormal rod outer segments in the peripheral retina, while cones (the cells responsible for color and detail vision) appeared normal at that stage.6PubMed. Progressive retinal atrophy in the Abyssinian cat. Electron microscopy As the disease advances, both rods and cones are lost, with the most severe damage in the midperipheral retina. By the advanced stage, seen in cats around six years old, virtually all photoreceptors were gone.
That progression explains what owners typically observe. The earliest sign is difficulty seeing in low light: a cat may hesitate before jumping off a bed at night or bump into furniture in dimly lit rooms. Because cats rely heavily on whiskers, hearing, and spatial memory, many compensate so successfully that owners attribute the clumsiness to aging or distraction. Daytime vision remains relatively intact for a while, because the cones survive longer. Eventually, central and color vision deteriorate too, and the cat becomes functionally blind.
The pupils also change as the disease progresses. In healthy cats, the pupillary light reflex shows a sharp initial constriction followed by a characteristic pattern of re-dilation and sustained constriction. Affected cats retain each component of the reflex, but their pupils become progressively less sensitive to light as the retina degenerates.7Wiley Online Library (Veterinary Ophthalmology). Effects of hereditary retinal degeneration due to a CEP290 mutation on the feline pupillary light reflex Veterinarians sometimes pick up on sluggish pupils during routine exams, which can prompt further investigation even before the owner notices behavioral changes.
How Veterinarians Diagnose PRA
A standard eye exam with an ophthalmoscope can reveal the hallmark signs of advanced PRA: increased reflectivity of the tapetum (the mirror-like layer behind the retina that gives cats their eyeshine), thinning of retinal blood vessels, and changes to the optic disc. But in early stages, the retina can look deceptively normal under direct examination.
Electroretinography (ERG) is the gold standard for catching PRA before visible retinal changes appear. It measures the electrical responses of the retina to flashes of light. In Abyssinian cats with early-stage disease, ERG recordings showed significant reductions in the a-wave and b-wave amplitudes at a time when other measurements of retinal function were still relatively normal.8PubMed Central. Progressive retinal atrophy in the Abyssinian cat: studies of the DC-recorded electroretinogram and the standing potential of the eye In practical terms, ERG can detect PRA before the cat or the owner knows anything is wrong, which is especially valuable for breeders deciding which cats to include in their programs.
DNA testing is the most definitive approach for known mutations. Commercial tests are available for the CEP290/rdAc mutation and the CRX mutation, typically using a cheek swab. For Persian and Bengal PRA, the causative genes have been localized but, at the time of the key mapping studies, specific commercial tests for those forms have been slower to arrive because the exact mutations hadn’t yet been pinpointed at the same level of detail as CEP290.9PubMed Central. Genome-wide association and linkage analyses localize a progressive retinal atrophy locus in Persian cats Breeders working with Persians or Bengals may still need to rely on ERG screening and pedigree analysis alongside whatever genetic tests become available.
Conditions That Mimic PRA
Not every case of progressive vision loss in a cat is PRA. One of the most important look-alikes is drug-induced retinal degeneration caused by fluoroquinolone antibiotics, particularly enrofloxacin (commonly sold under the brand name Baytril). This antibiotic, widely used in veterinary practice for bacterial infections, can be directly toxic to the cat retina.10PubMed. Enrofloxacin-associated retinal degeneration in cats Unlike PRA, which takes months to years, fluoroquinolone toxicity can cause acute and widespread retinal damage, sometimes within days of starting treatment.
The underlying mechanism involves a transporter protein called ABCG2 at the blood-retinal barrier. When this transporter doesn’t function properly, photoreactive fluoroquinolone molecules accumulate in the retina. Exposure to light then generates reactive oxygen species that damage the photoreceptors.11Pharmacogenetics and Genomics. Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats The damage can be permanent. Veterinarians have become increasingly cautious with fluoroquinolone dosing in cats as a result, but owners should be aware of this risk whenever these antibiotics are prescribed, especially at higher doses or for extended courses.
Other conditions that can cause similar-looking retinal changes include hypertensive retinopathy (retinal detachment from high blood pressure, common in older cats with kidney disease or hyperthyroidism), taurine deficiency (now rare because commercial cat foods are supplemented), and nutritional deficiencies in cats fed inappropriate diets. A key difference is that PRA is bilateral and symmetric from the start, affecting both eyes equally, whereas drug toxicity or hypertensive damage can sometimes be asymmetric or sudden in onset.
Living with a Blind or Vision-Impaired Cat
There is currently no approved treatment that reverses PRA once photoreceptors are lost. That is a hard reality, but the practical picture is less grim than it sounds. Cats that lose their vision gradually tend to adapt remarkably well, especially in familiar environments. Their spatial memory is excellent, and their other senses, particularly hearing, whisker sensitivity, and smell, compensate for a great deal.
A few practical adjustments help visually impaired cats navigate safely. Keeping furniture in consistent positions matters more than most owners expect; rearranging a room can disorient a blind cat for days. Blocking access to balconies, open stairwells, or pools eliminates the biggest physical hazards. Many owners find that talking to their cat more often, especially when entering a room or approaching to pick them up, reduces startle responses. Scent markers (different air fresheners or textured mats near doorways) can help a cat map out the home.
Indoor-only living is strongly recommended once significant vision loss is detected. Outdoor environments change unpredictably, and a blind cat cannot spot approaching cars, dogs, or other threats. Cats that have always been indoor cats usually adjust to blindness with minimal behavioral change. Cats used to outdoor access may go through a period of frustration, but most settle into new routines within a few weeks.
Gene Therapy Research
Researchers have been working toward gene therapy for inherited retinal diseases in cats for years, and there has been genuine progress. Cats with PRA serve as large animal models for similar human conditions, and their eyes are large enough to accommodate the same surgical techniques used in human patients.12PubMed Central. The domestic cat as a large animal model for characterization of disease and therapeutic intervention in hereditary retinal blindness That has made them valuable not just for understanding feline blindness but for advancing human treatments as well.
The most striking recent results have come from work on the dominant CRX form of retinal degeneration. Researchers used a combined approach: an AAV (adeno-associated virus) vector delivered both a molecule to silence the faulty CRX gene and a corrected copy of the human CRX gene that resists the silencing molecule. In a preclinical trial, treated cats showed ERG rescue in 14 eyes, preservation of retinal layer thickness in treated areas, and measurable recovery of visual tracking behavior.13Investigative Ophthalmology & Visual Science. Gene therapy recovers vision and retinal function in a cat model of adCRX-LCA7 Cats treated early enough showed prevention of nystagmus (the involuntary eye movements associated with severe vision loss), and when both rods and cones were targeted, the recovery was sustained. This is still preclinical work, meaning it has not yet been approved for routine veterinary use, but it demonstrates that vision restoration is achievable if treatment comes before too many photoreceptors are lost.
Gene therapy research in dogs with their own forms of progressive retinal atrophy has moved even further along and helped pave the way for the human gene therapy Luxturna, which treats a specific inherited retinal disease in people.14PubMed Central. Gene therapy advances using canine and feline animal models of inherited retinal degeneration Feline models are now being used to tackle dominant mutations, which are harder to treat because you can’t simply add a working gene; you also have to suppress the toxic product of the faulty one. The combined knockdown-and-replace strategy tested in CRX cats represents a potential blueprint for treating dominant retinal diseases in people.
Genetic Testing and Breeding Decisions
For breeders, the single most effective tool against PRA is DNA testing before mating. Because most forms of feline PRA are recessive, carrier-to-carrier matings are the primary source of affected kittens. A straightforward testing program can eliminate affected offspring within a single generation without drastically narrowing the gene pool: carriers can still be bred, but only to cats that test clear, ensuring no kitten inherits two copies of the mutation.
The challenge is that not all forms of PRA have commercially available DNA tests yet. The rdAc (CEP290) test covers the widest range of breeds, and the CRX test covers Siamese-derived lines. For Persian PRA, the disease locus has been mapped to a small region on chromosome E1, but identifying the exact mutation took additional work after the initial mapping study.15PubMed Central. Genome-wide association and linkage analyses localize a progressive retinal atrophy locus in Persian cats Bengal PRA is in a similar position: characterized clinically and confirmed as a separate genetic entity, but the specific gene is not yet publicly identified.16PubMed Central. Characterization of an Early-Onset, Autosomal Recessive, Progressive Retinal Degeneration in Bengal Cats
Breed clubs and registries vary widely in whether they require or even recommend PRA testing. Some Abyssinian and Somali breed clubs have been proactive about requiring CEP290 testing for registered breeding cats, which has reduced the frequency of affected kittens in those lines. Other breeds, especially those where PRA was only recently discovered to be a concern, lag behind. If you are purchasing a kitten from a breed known to carry PRA mutations, asking for proof of genetic testing of both parents is reasonable and responsible, even if the breed club doesn’t mandate it.
Why Cats with PRA Matter to Human Medicine
Feline PRA isn’t just a veterinary problem. The Abyssinian cat has become one of the best-characterized large animal models for retinitis pigmentosa, the equivalent human condition. Because the cat eye is much closer in size and structure to the human eye than a mouse eye, surgical techniques developed in cats translate more directly to human patients.17Digital Journal of Ophthalmology. Photoreceptor Degeneration in a Selected Animal Model: The Abyssinian Cat Routine ophthalmic procedures, including ERG, optical coherence tomography, and subretinal injections, can be performed in cats using the same equipment and approaches used in human clinics.
The CRX cat model is especially relevant to human medicine because dominant retinal degenerations make up a significant proportion of inherited blindness in people, and they are harder to treat than recessive forms. The preclinical gene therapy success in CRX cats, where researchers managed to both knock down the harmful gene product and replace it with a functional copy, opens a therapeutic path that could eventually apply to human patients with dominant mutations in the same gene.18Investigative Ophthalmology & Visual Science. Gene therapy recovers vision and retinal function in a cat model of adCRX-LCA7 Research on these cats doesn’t just benefit the cats themselves; it pushes forward the entire field of retinal gene therapy in ways that mouse models alone cannot accomplish.
Interestingly, the study of photoreceptor death in feline retinal degeneration has also revealed basic biology about how retinal cells die. Experiments using ATP injections in cat eyes confirmed that high concentrations cause photoreceptor-specific cell death while leaving other retinal layers largely intact, providing a controlled tool for studying the mechanisms of degeneration.19Investigative Ophthalmology & Visual Science. ATP-Induced Photoreceptor Death in a Feline Model of Retinal Degeneration Insights from that kind of work help researchers understand not just inherited diseases but also age-related retinal degeneration in both cats and people.